Tag Archives: Paul Cole

The Unacknowledged Role of Section 112 in the Myriad Decisions

Guest post from Paul Cole, Lucas & Co., UK; introduction by Warren Woessner. In this interesting note, Paul Cole explores the possible effect on the Fed. Cir. and Supreme Court’s decisions about the patent-eligibility  of “genomic DNA” of the arguable … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Case Law of the EPO Boards of Appeal Released

Thanks to correspondent Paul Cole of Lucas &Co. for sending us the below notice. Students of patent law will welcome the 7th edition of this well-known compilation which went live on the EPO website on 4th October. It is now … Continue reading

Posted in EP and UK Practice | Tagged , , , , , | Leave a comment

Association For Molecular Pathology V Myriad Genetics – An Isolated Local Difficulty?

Paul Cole, Professor of Intellectual Property Law at Bournemouth University and European Patent Attorney at Lucas & Co, Warlingham, Surrey, UK discusses yesterdays Myriad ruling by the Supreme Court. How does yesterday’s Supreme Court decision match international opinion on the patentability … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Mayo v. Prometheus – A European View

A Guest Post from Paul Cole, European Patent Attorney, Lucas & Co; Professor of IP law, Bournemouth University. Is a claim to an assay patent-eligible when all its features are known save for how it should be interpreted? The interpretation … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 3 Comments